Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 5
1960 2
1961 5
1962 10
1963 10
1964 6
1965 5
1966 5
1967 6
1968 8
1969 9
1970 16
1971 20
1972 17
1973 38
1974 20
1975 26
1976 35
1977 34
1978 31
1979 32
1980 38
1981 32
1982 52
1983 40
1984 52
1985 50
1986 59
1987 70
1988 132
1989 148
1990 150
1991 129
1992 139
1993 165
1994 207
1995 247
1996 303
1997 373
1998 467
1999 579
2000 746
2001 875
2002 1018
2003 1231
2004 1509
2005 1762
2006 2078
2007 2351
2008 2740
2009 3163
2010 3691
2011 4278
2012 4858
2013 5147
2014 5641
2015 5985
2016 6107
2017 6257
2018 6376
2019 6520
2020 7470
2021 8008
2022 7401
2023 7215
2024 5763
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99,630 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Kim H, Nguyen LH. Kim H, et al. Gastroenterology. 2024 Sep 21:S0016-5085(24)05482-9. doi: 10.1053/j.gastro.2024.09.020. Online ahead of print. Gastroenterology. 2024. PMID: 39307254 No abstract available.
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. Among authors: kim hj. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471061 Free PMC article. Clinical Trial.
Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage.
Yoon JH, Jin H, Kim HJ, Hong SP, Yang MJ, Ahn JH, Kim YC, Seo J, Lee Y, McDonald DM, Davis MJ, Koh GY. Yoon JH, et al. Among authors: kim hj. Nature. 2024 Jan;625(7996):768-777. doi: 10.1038/s41586-023-06899-4. Epub 2024 Jan 10. Nature. 2024. PMID: 38200313 Free PMC article.
INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10.
Zhang W, Zhao J, Deng L, Ishimwe N, Pauli J, Wu W, Shan S, Kempf W, Ballantyne MD, Kim D, Lyu Q, Bennett M, Rodor J, Turner AW, Lu YW, Gao P, Choi M, Warthi G, Kim HW, Barroso MM, Bryant WB, Miller CL, Weintraub NL, Maegdefessel L, Miano JM, Baker AH, Long X. Zhang W, et al. Among authors: kim hw. Circulation. 2023 Jul 4;148(1):47-67. doi: 10.1161/CIRCULATIONAHA.123.063760. Epub 2023 May 18. Circulation. 2023. PMID: 37199168 Free PMC article.
Identification of small molecule inhibitors of G3BP-driven stress granule formation.
Freibaum BD, Messing J, Nakamura H, Yurtsever U, Wu J, Kim HJ, Hixon J, Lemieux RM, Duffner J, Huynh W, Wong K, White M, Lee C, Meyers RE, Parker R, Taylor JP. Freibaum BD, et al. Among authors: kim hj. J Cell Biol. 2024 Mar 4;223(3):e202308083. doi: 10.1083/jcb.202308083. Epub 2024 Jan 29. J Cell Biol. 2024. PMID: 38284934 Free PMC article.
JPRM cerebral palsy special issue 2023.
Kim H, Byrne R, Green M. Kim H, et al. J Pediatr Rehabil Med. 2023;16(1):1-2. doi: 10.3233/PRM-239002. J Pediatr Rehabil Med. 2023. PMID: 36938746 Free PMC article. No abstract available.
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.
Kim CG, Hong MH, Kim D, Lee BH, Kim H, Ock CY, Kelly G, Bang YJ, Kim G, Lee JE, Kim C, Kim SH, Hong HJ, Park YM, Sim NS, Park H, Park JW, Lee CG, Kim KH, Park G, Jung I, Han D, Kim JH, Cha J, Lee I, Kang M, Song H, Oum C, Kim S, Kim S, Lim Y, Kim-Schulze S, Merad M, Yoon SO, Kim HJ, Koh YW, Kim HR. Kim CG, et al. Among authors: kim h, kim hj, kim hr. Clin Cancer Res. 2024 May 15;30(10):2097-2110. doi: 10.1158/1078-0432.CCR-23-3249. Clin Cancer Res. 2024. PMID: 38457288 Clinical Trial.
99,630 results
You have reached the last available page of results. Please see the User Guide for more information.